Literature DB >> 19473757

MAC-related mitochondrial pathway in oroxylin-A-induced apoptosis in human hepatocellular carcinoma HepG2 cells.

Wei Liu1, Rong Mu, Fei-Fei Nie, Yong Yang, Jun Wang, Qin-Sheng Dai, Na Lu, Qi Qi, Jing-Jing Rong, Rong Hu, Xiao-Tang Wang, Qi-Dong You, Qing-Long Guo.   

Abstract

Oroxylin A is a flavonoid isolated from the root of Scutellaria baicalensis Georgi. Our previous work demonstrated that the anti-tumor activity of oroxylin A was mainly attributed to its apoptosis inducing effect in cells. The present study explores the exact molecular mechanism of oroxylin A-induced apoptosis in tumor cells. We showed that oroxylin A-induced apoptosis in HepG2 cells was achieved through mitochondrial pathway. We also investigated which mitochondrial channels, PTP or MAC or both, were involved in the permeabilization of the mitochondrial outer membrane after treatment with oroxylin A. The results showed that oroxylin A-induced apoptosis in a PTP-independent manner; therefore, we focused our attention on MAC. As Bax is an essential constituent of MAC in certain systems, we examined the activation, subcellular location, oligomeric structure of Bax in HepG2 cells treated with oroxylin A. Moreover, our results showed that overexpression of Bcl-2 inhibited oroxylin A-induced apoptosis. In summary, we have demonstrated that opening of MAC, but not PTP, played a key role in oroxylin A-induced activation of mitochondrial apoptotic pathway in HepG2 cells. 2009 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473757     DOI: 10.1016/j.canlet.2009.04.021

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

Review 1.  Anticancer potential of oroxylin A: from mechanistic insight to synergistic perspectives.

Authors:  Hardeep Singh Tuli; Vivek Kumar Garg; Ajay Kumar; Diwakar Aggarwal; Uttpal Anand; Nidarshana Chaturvedi Parashar; Adesh K Saini; Ranjan K Mohapatra; Kuldeep Dhama; Manoj Kumar; Tejveer Singh; Jagjit Kaur; Katrin Sak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-10       Impact factor: 3.195

Review 2.  Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds.

Authors:  Abedul Haque; Daniel Brazeau; Arm R Amin
Journal:  Eur J Cancer       Date:  2021-04-14       Impact factor: 9.162

3.  Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization.

Authors:  L Wei; Y Zhou; C Qiao; T Ni; Z Li; Q You; Q Guo; N Lu
Journal:  Cell Death Dis       Date:  2015-04-09       Impact factor: 8.469

Review 4.  Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Authors:  Xuanbin Wang; Yibin Feng; Ning Wang; Fan Cheung; Hor Yue Tan; Sen Zhong; Charlie Li; Seiichi Kobayashi
Journal:  Biomed Res Int       Date:  2014-10-14       Impact factor: 3.411

Review 5.  Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma.

Authors:  Chen-Yi Liao; Ching-Chang Lee; Chi-chang Tsai; Chao-Wen Hsueh; Chih-Chiang Wang; I-Hung Chen; Ming-Kai Tsai; Mei-Yu Liu; An-Tie Hsieh; Kuan-Jen Su; Hau-Ming Wu; Shih-Chung Huang; Yi-Chen Wang; Chien-Yao Wang; Shu-Fang Huang; Yen-Cheng Yeh; Ren-Jy Ben; Shang-Tao Chien; Chin-Wen Hsu; Wu-Hsien Kuo
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

6.  Oroxylin A inhibits the generation of Tregs in non-small cell lung cancer.

Authors:  Le Shen; Lu-Lu Zhang; Hui Li; Xiao Liu; Xiao-Xuan Yu; Po Hu; Hui Hui; Qing-Long Guo; Shuai Zhang
Journal:  Oncotarget       Date:  2017-07-25

7.  Triggering apoptosis by oroxylin A through caspase-8 activation and p62/SQSTM1 proteolysis.

Authors:  Yue Zhao; Qin Zhu; Xiumin Bu; Yihui Zhou; Dongsheng Bai; Qinglong Guo; Yuan Gao; Na Lu
Journal:  Redox Biol       Date:  2019-11-28       Impact factor: 11.799

8.  Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma.

Authors:  L Wei; Y Zhou; Q Dai; C Qiao; L Zhao; H Hui; N Lu; Q-L Guo
Journal:  Cell Death Dis       Date:  2013-04-18       Impact factor: 8.469

9.  Oroxylin A modulates mitochondrial function and apoptosis in human colon cancer cells by inducing mitochondrial translocation of wild-type p53.

Authors:  Chen Qiao; Na Lu; Yuxin Zhou; Ting Ni; Yuanyuan Dai; Zhiyu Li; Qinglong Guo; Libin Wei
Journal:  Oncotarget       Date:  2016-03-29

10.  Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression.

Authors:  Libin Wei; Yuanyuan Dai; Yuxin Zhou; Zihao He; Jingyue Yao; Li Zhao; Qinglong Guo; Lin Yang
Journal:  Cell Death Dis       Date:  2017-07-20       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.